Page last updated: 2024-08-25

tetrandrine and Intestinal Diseases

tetrandrine has been researched along with Intestinal Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chang, L; Chu, Y; Dai, Y; Guo, Y; Liu, X; Wei, Z; Xia, Y; Yun, X; Zhang, Y; Zhu, Y	1

Other Studies

1 other study(ies) available for tetrandrine and Intestinal Diseases

Article	Year
Tetrandrine attenuates intestinal epithelial barrier defects caused by colitis through promoting the expression of Occludin via the AhR-miR-429 pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021, Volume: 35, Issue:5 Topics: Animals; Benzylisoquinolines; Calcium Channel Blockers; Colitis; Dextran Sulfate; Female; Gene Expression Regulation; Humans; Intestinal Diseases; Intestinal Mucosa; Mice; Mice, Inbred C57BL; MicroRNAs; Occludin; Permeability; Receptors, Aryl Hydrocarbon	2021

Article

Year

Tetrandrine attenuates intestinal epithelial barrier defects caused by colitis through promoting the expression of Occludin via the AhR-miR-429 pathway.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021, Volume: 35, Issue:5

Topics: Animals; Benzylisoquinolines; Calcium Channel Blockers; Colitis; Dextran Sulfate; Female; Gene Expression Regulation; Humans; Intestinal Diseases; Intestinal Mucosa; Mice; Mice, Inbred C57BL; MicroRNAs; Occludin; Permeability; Receptors, Aryl Hydrocarbon

2021